
---
title: '呼吸道合胞病毒疫苗和单抗最新研究进展（9）'
categories: 
 - 新媒体
 - 科学网
 - 博客
headimg: 'https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=953242'
author: 科学网
comments: false
date: Sun, 28 Aug 2022 12:34:00 GMT
thumbnail: 'https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=953242'
---

<div>   
<h1 style="margin-top:0;margin-right:0;margin-bottom:0;margin-left:0;padding:0 0 0 0 "><strong style="font-size: 16px;"><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 35px">呼吸道合</span></strong><strong style="font-size: 16px;"><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 35px">胞病毒预防制剂曙光在前:　</span></strong></h1><p style="margin-top:30px;margin-right:0;margin-bottom:54px;margin-left:0;text-indent:0;padding:0 0 0 0 ;background:rgb(255,255,255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 35px">疫苗和单克隆抗体百舸争流</span></strong></p><p style="margin-top:30px;margin-right:0;margin-bottom:54px;margin-left:0;text-indent:0;padding:0 0 0 0 ;background:rgb(255,255,255)"><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px">前言：</span></strong></p><p style="margin-top:30px;margin-right:0;margin-bottom:54px;margin-left:0;text-indent:0;padding:0 0 0 0 ;background:rgb(255,255,255)"><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px"><span style="font-family:Microsoft YaHei UI">　　新冠病毒大流行的将近３年，也是世界疫苗行业突飞猛进、疫苗研发技术日新月异、硕果累累的３年。疫苗制备的多种技术途径都得到深度开发，若干种新兴的技术途径如</span><span style="font-family:Microsoft YaHei UI">mRNA疫苗获得了空前的成功，在世界各地大行其道，在多种传染病以及癌症和其他慢性病的防治领域都在不断开花结果。</span></span></strong></p><p style="margin-top:30px;margin-right:0;margin-bottom:54px;margin-left:0;text-indent:0;padding:0 0 0 0 ;background:rgb(255,255,255)"><strong>　　　　</strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 0;font-size: 24px"><span style="font-family:Microsoft YaHei UI">呼吸道合胞病毒（</span></span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 24px">Respiratory syncytial virus，</span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 0;font-size: 24px"><span style="font-family:Microsoft YaHei UI">RSV</span></span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 24px"><span style="font-family:Shaker2Lancet-Bold">）</span></span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px"><span style="font-family:Microsoft YaHei UI">是一种历史悠久、危害极大的传染病，其疫苗的研发已经有四十年的历史，</span><span style="font-family:Microsoft YaHei UI"> 但最初开发的疫苗反而会引发</span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 0;font-size: 24px"><span style="font-family:Microsoft YaHei UI">疫苗相关性呼吸道疾病（</span><span style="font-family:Microsoft YaHei UI">VAERD，Vaccine-associated enhanced respiratory diseases</span></span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 0;font-size: 24px">）</span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px">，即未接触过</span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 0;font-size: 24px"><span style="font-family:Microsoft YaHei UI">RSV</span></span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px">的儿童在接种了疫苗后，如果再接触到该病毒反而会发生更严重的</span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 0;font-size: 24px"><span style="font-family:Microsoft YaHei UI">RSV</span></span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px">疾病。诸如此类的问题导致针对</span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 0;font-size: 24px"><span style="font-family:Microsoft YaHei UI">RSV</span></span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px">的疫苗一直未能上市。乘新冠病毒疫苗大跃进的东风，已赚得盆满钵满的疫苗巨头如</span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px"><span style="font-family:Microsoft YaHei UI">辉瑞（</span><span style="font-family:Microsoft YaHei UI">Pfizer)</span></span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px">、</span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px"><span style="font-family:Microsoft YaHei UI">莫德纳（</span><span style="font-family:Microsoft YaHei UI">Moderna</span></span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px">）和</span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px"><span style="font-family:Microsoft YaHei UI">葛兰素史克</span><span style="font-family:Microsoft YaHei UI">(GSK)</span></span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px">等目前都在</span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 0;font-size: 24px"><span style="font-family:Microsoft YaHei UI">RSV</span></span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px">的疫苗开发上快马加鞭，有望在较短时间内取得重大突破。</span></strong></p><p style="margin-top:30px;margin-right:0;margin-bottom:54px;margin-left:0;text-indent:0;padding:0 0 0 0 ;background:rgb(255,255,255)"><strong>　　　　</strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 0;font-size: 24px"><span style="font-family:Microsoft YaHei UI">RSV</span></span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px">疫苗和单克隆抗体研究领域来自世界各地的顶级研究人员（约５０人）近期联名在国际著名专业杂志《</span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #FF0000;letter-spacing: 0;font-size: 24px">Lancet</span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px"> Infect Dis》上发表综述论文，介绍相关最新研究进展（见</span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #222222;letter-spacing: 0;font-size: 24px">参考文献</span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px">），本博客将分数次介绍此综述的主要内容。</span></strong></p><p style="margin: 30px 0px 54px; text-indent: 0px; padding: 0px; background: rgb(255, 255, 255); line-height: normal;"><span style="font-size: 36px;"><strong style="text-indent: 43px;"><span style="line-height: 200%; font-family: SimSun;"><strong style="white-space: normal;"><span style="line-height: 200%; font-family: Shaker2Lancet-Bold; color: #231F20; letter-spacing: 1px; font-size: 35px;">目录</span></strong></span></strong></span><span style="font-size: 36px;"><strong style="text-indent: 43px;"><span style="line-height: 200%; font-family: SimSun;">：</span></strong></span></p><p style="text-indent: 43px; line-height: normal;"><strong><span style="font-family: Calibri;line-height: 200%;font-size: 24px"><span style="font-family:SimSun">摘要</span></span></strong></p><p style="text-indent:43px;text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: Calibri;line-height: 200%;font-size: 24px"><span style="font-family:SimSun">一</span>.<span style="font-family:SimSun">　前言</span></span></strong></p><p style="text-indent:43px;text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: Calibri;line-height: 200%;font-size: 24px"><span style="font-family:SimSun">二</span>.<span style="font-family:SimSun">　方法</span></span></strong></p><p style="text-indent:43px;text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: Calibri;line-height: 200%;font-size: 24px"><span style="font-family:SimSun">三</span>.<span style="font-family:SimSun">　教训（</span><span style="font-family:Calibri">Lessons learned</span><span style="font-family:SimSun">）</span></span></strong></p><p style="text-indent:43px;text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: Calibri;line-height: 200%;font-size: 24px"><span style="font-family:SimSun">四</span>.<span style="font-family:SimSun">　活的减毒疫苗（</span><span style="font-family:Calibri">liveattenuated vaccines</span><span style="font-family:SimSun">，</span><span style="font-family:Calibri">LAVs </span><span style="font-family:SimSun">）</span></span></strong></p><p style="text-indent:43px;text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: Calibri;line-height: 200%;font-size: 24px"><span style="font-family:SimSun">五</span>.<span style="font-family:SimSun">　嵌合疫苗（</span><span style="font-family:Calibri">Chimeric </span><span style="font-family:SimSun">）</span></span></strong></p><p style="text-indent:43px;text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: Calibri;line-height: 200%;font-size: 24px"><span style="font-family:SimSun">六</span>.<span style="font-family:SimSun">　亚单位疫苗（</span><span style="font-family:Calibri">Subunit</span><span style="font-family:SimSun">）</span></span></strong></p><p style="text-indent:43px;text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: Calibri;line-height: 200%;font-size: 24px"><span style="font-family:SimSun">七</span>.<span style="font-family:SimSun">　基于颗粒的疫苗（</span><span style="font-family:Calibri">Particle-based </span><span style="font-family:SimSun">）</span></span></strong></p><p style="text-indent:43px;text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: Calibri;line-height: 200%;font-size: 24px"><span style="font-family:SimSun">八</span>.<span style="font-family:SimSun">　核酸疫苗（</span><span style="font-family:Calibri">Nucleic acid</span><span style="font-family:SimSun">）</span></span></strong></p><p style="text-indent:43px;text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: Calibri;line-height: 200%;font-size: 24px"><span style="font-family:SimSun">九</span>.<span style="font-family:SimSun">　重组载体疫苗（</span><span style="font-family:Calibri">Recombinant vectors</span><span style="font-family:SimSun">）</span></span></strong></p><p style="text-indent:43px;text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: Calibri;line-height: 200%;font-size: 24px"><span style="font-family:SimSun">十</span>.<span style="font-family:SimSun">　单克隆抗体（</span><span style="font-family:Calibri">MAbs</span><span style="font-family:SimSun">）</span></span></strong></p><p style="text-indent:43px;text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: Calibri;line-height: 200%;font-size: 24px"><span style="font-family:SimSun">十一</span>.<span style="font-family:SimSun">　讨论</span><span style="font-family:Calibri"> </span></span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 29px"><span style="font-family:SimSun">图</span><span style="font-family:Calibri">4:</span>　<span style="font-family:Calibri">RSV</span><span style="font-family:SimSun">疫苗和免疫预防制剂在过去</span><span style="font-family:Calibri">10</span><span style="font-family:SimSun">年间的发展历史、现状和预期市场前景。</span></span></strong></p><p style="text-indent:43px;text-autospace:ideograph-numeric;line-height:200%"><strong><span style="text-decoration:underline;"><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:Calibri">RSV </span></span></span></strong><span style="text-decoration:underline;"><span style="font-family: SimSun;line-height: 200%;font-size: 21px">（呼吸道合胞体病毒</span></span><span style=";font-family:SimSun;line-height:200%;font-size:21px">）正在开发中的候选疫苗（用</span><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px">蓝色</span></strong><span style=";font-family:SimSun;line-height:200%;font-size:21px"><span style="font-family:SimSun">标记</span><span style="font-family:Calibri">)</span><span style="font-family:SimSun">或已停止开发的候选疫苗</span><span style="font-family:Calibri">(</span><span style="font-family:SimSun">用</span></span><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px">红色</span></strong><span style=";font-family:SimSun;line-height:200%;font-size:21px"><span style="font-family:SimSun">标记</span><span style="font-family:Calibri">)</span><span style="font-family:SimSun">显示其进行临床试验的年份。</span></span></p><p style="text-indent:43px;text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:SimSun;line-height:200%;font-size:21px"><span style="font-family:SimSun">颜色的深浅代表候选疫苗开发在</span><span style="font-family:Calibri">1</span><span style="font-family:SimSun">期、</span><span style="font-family:Calibri">2</span><span style="font-family:SimSun">期或</span><span style="font-family:Calibri">3</span><span style="font-family:SimSun">期临床试验系列中最多达到的阶段。</span></span></p><p style="text-indent:43px;text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:SimSun;line-height:200%;font-size:21px">进行过多次临床试验的候选疫苗用</span><span style="text-decoration:underline;"><span style="font-family: SimSun;line-height: 200%;font-size: 21px">实线</span></span><span style=";font-family:SimSun;line-height:200%;font-size:21px">或</span><span style="text-decoration:underline;"><span style="font-family: SimSun;line-height: 200%;font-size: 21px">虚线</span></span><span style=";font-family:SimSun;line-height:200%;font-size:21px">连接，以显示其开发进度。实线连接的项目的开发还在继续进行，虚线连接的项目的开发已经中止。</span></p><p style="text-indent:43px;text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:SimSun;line-height:200%;font-size:21px">由于同一个制造商生产的减毒活病毒疫苗的开发过程有很大的重叠，因此这些候选活病毒都被汇集在一个</span><span style="text-decoration:underline;"><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:SimSun">方格（</span><span style="font-family:Calibri">box</span></span></span><span style=";font-family:SimSun;line-height:200%;font-size:21px">）里。</span></p><p style="text-indent:43px;text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:SimSun;line-height:200%;font-size:21px"><span style="font-family:SimSun">当前和以前有关</span><span style="font-family:Calibri">RSV</span><span style="font-family:SimSun">疫苗的三篇</span></span><span style="text-decoration:underline;"><span style="font-family: SimSun;line-height: 200%;font-size: 21px">综述论文</span></span><span style=";font-family:SimSun;line-height:200%;font-size:21px"><span style="font-family:SimSun">的发表年份显示在最下方，分别是</span><span style="font-family:Calibri">2015</span><span style="font-family:SimSun">年、</span><span style="font-family:Calibri">2018</span><span style="font-family:SimSun">年和今年（</span><span style="font-family:Calibri">2022</span><span style="font-family:SimSun">年）。</span></span></p><p style="text-indent:43px;text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:Calibri">RSV</span></span></strong>　<span style="text-decoration:underline;"><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:Calibri">PreF (M)</span><span style="font-family:SimSun">（前融合蛋白</span></span></span><span style=";font-family:SimSun;line-height:200%;font-size:21px">）候选疫苗的开发没</span><span style=";font-family:SimSun;line-height:200%;font-size:21px"><span style="font-family:SimSun">有终止，而只是暂停</span><span style="font-family:Calibri">(</span><span style="font-family:SimSun">虚线连接的方格</span><span style="font-family:Calibri">)</span><span style="font-family:SimSun">。</span></span></p><p style="text-indent:44px;text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:SimSun;line-height:200%;font-size:21px"><span style="font-family:SimSun">图中</span><span style="font-family:Calibri">2022</span></span><span style=";font-family:SimSun;line-height:200%;font-size:21px">年及以后的项目为有希望注册的制剂。</span><span style="text-decoration:underline;"><span style="font-family: SimSun;line-height: 200%;font-size: 21px">预期注册年份</span></span><span style=";font-family:SimSun;line-height:200%;font-size:21px"><span style="font-family:SimSun">的估计是在公布中期试验结果后增加</span><span style="font-family:Calibri">1</span><span style="font-family:SimSun">年；如果没有可用的数据，则依据在网站</span><span style="font-family:Calibri">ClinicalTrials.gov</span><span style="font-family:SimSun">上公布的预计完成年份再增加</span><span style="font-family:Calibri">1</span><span style="font-family:SimSun">年。在完成了</span><span style="font-family:Calibri">1/2</span><span style="font-family:SimSun">期或</span><span style="font-family:Calibri">2/3</span><span style="font-family:SimSun">期临床试验的项目中，只采用最多达到的临床试验阶段。　　</span></span></p><p style="text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:Calibri;line-height:200%;font-size:21px"><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=953242" title alt="image.png" referrerpolicy="no-referrer"></span></p><p style="text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:Calibri;line-height:200%;font-size:21px"><span style="font-family: SimSun;">图例：</span></span></p><p style="text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:Calibri;line-height:200%;font-size:21px">   </span><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=953240" title alt="image.png" referrerpolicy="no-referrer"><span style=";font-family:SimSun;line-height:200%;font-size:21px">分别表示已暂停（</span><span style=";font-family:SimSun;line-height:200%;font-size:21px"><span style="font-family:Calibri">halted</span><span style="font-family:SimSun">）</span></span><span style=";font-family:SimSun;line-height:200%;font-size:21px">的１期、２期和３期临床试验。</span></p><p style="text-autospace:ideograph-numeric;line-height:200%"><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=953241" title alt="image.png" referrerpolicy="no-referrer"><span style=";font-family:Calibri;line-height:200%;font-size:21px"> </span><span style=";font-family:SimSun;line-height:200%;font-size:21px">分别表示正在进行的１期、２期和３期临床试验。</span><span style=";font-family:Calibri;line-height:200%;font-size:21px">       </span></p><p style="text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:Calibri;line-height:200%;font-size:21px">  </span><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=953243" title alt="image.png" referrerpolicy="no-referrer"><span style=";font-family:SimSun;line-height:200%;font-size:21px">　表示近期已暂停的开发项目。</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><strong><span style="font-family: SimSun;color: #333333;letter-spacing: 0;font-size: 21px">（未完待续）</span></strong></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><strong><span style="font-family: SimSun;color: #333333;letter-spacing: 0;font-size: 24px">参考文献：</span></strong></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><em><span style="font-family: Shaker2Lancet-Italic;color: #006F3C;letter-spacing: 0;font-size: 20px">Natalie I Mazur,</span></em><em>　</em><em><span style="font-family: Shaker2Lancet-Italic;color: #006F3C;letter-spacing: 0;font-size: 20px">et al., </span></em><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 20px">Respiratory syncytial virus prevention within reach:</span></strong><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 20px"> the vaccine and monoclonal antibody landscape, </span></strong><em><span style="font-family: Shaker2Lancet-Bold;color: #FF0000;letter-spacing: 0;font-size: 20px">Lancet Infect Dis</span></em><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 20px"><span style="font-family:Shaker2Lancet-Bold">，</span> Published online August 8, 2022， </span></strong><span style="font-family: Tahoma;color: #505050;letter-spacing: 0;font-size: 20px">DOI: </span><a href="https://doi.org/10.1016/S1473-3099(22)00291-2" target="_blank"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 20px">https://doi.org/10.1016/S1473-3099(22)00291-2</span></a><span style="font-family: SimSun;color: #333333;letter-spacing: 0;font-size: 20px">，</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><a href="https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00291-2/fulltext" target="_blank"><span style="text-decoration:underline;"><span style="font-family: Shaker2Lancet-Bold;color: #6666CC;letter-spacing: 0;font-size: 20px">https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00291-2/fulltext</span></span></a><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 20px">.</span></strong></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 24px">相关博文：</span></strong><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1350903" target="_blank"></a></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;background:rgb(255,255,255)"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1350903" target="_blank"><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=953248" title alt="image.png" referrerpolicy="no-referrer"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">呼吸道合胞病毒疫苗和单抗最新研究进展（１）</span></span></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 20px"> 2022-08-12</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;background:rgb(255,255,255)"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1350986" target="_blank"><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=953247" title alt="image.png" referrerpolicy="no-referrer"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">呼吸道合胞病毒疫苗和单抗最新研究进展（</span>2）</span></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px"> 2022-08-13</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;background:rgb(255,255,255)"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1351276" target="_blank"></a><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=953246" title alt="image.png" referrerpolicy="no-referrer"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1351276" target="_blank"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">呼吸道合胞病毒疫苗和单抗最新研究进展（</span>3）</span></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px"> 2022-08-15</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;background:rgb(255,255,255)"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1351490" target="_blank"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">呼吸道合胞病毒疫苗和单抗最新研究进展（</span>4）</span></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px"> 2022-08-17</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;background:rgb(255,255,255)"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1351871" target="_blank"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">呼吸道合胞病毒疫苗和单抗最新研究进展（</span>5）</span></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px"> 2022-08-20</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1352158" target="_blank"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">呼吸道合胞病毒疫苗和单抗最新研究进展（</span>6）</span></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px"> 2022-08-22</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1352448" target="_blank"><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=953245" title alt="image.png" referrerpolicy="no-referrer"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">呼吸道合胞病毒疫苗和单抗最新研究进展（</span>7）</span></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px"> 2022-08-24</span></p><p style="line-height: 200%;"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1352713" target="_blank"><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=953244" title alt="image.png" referrerpolicy="no-referrer"><strong><span style="font-family: Tahoma;line-height: 200%;color: #6666CC;letter-spacing: 0;font-size: 19px;background: #FFFFFF"><span style="font-family:Tahoma">呼吸道合胞病毒疫苗和单抗最新研究进展（</span>8）</span></strong></a><span style="font-family: Tahoma;line-height: 200%;color: #666666;letter-spacing: 0;font-size: 19px;background: #FFFFFF"> 2022-08-26</span></p>                    <br><br>
                                        <label style="font-size:13px; color:#850f0f">转载本文请联系原作者获取授权，同时请注明本文来自严家新科学网博客。<br>链接地址：</label><a href="https://blog.sciencenet.cn/blog-347754-1352981.html" target="_blank" style="font-size:13px; color:#850f0f">https://blog.sciencenet.cn/blog-347754-1352981.html </a>
  <br><br>上一篇：<a href="http://blog.sciencenet.cn/blog-347754-1352713.html" target="_black">呼吸道合胞病毒疫苗和单抗最新研究进展（8）</a><br>                    <!--大赛结束-->
                                        
  
</div>
            